Drug Shortage Report for CEFUROXIME FOR INJECTION, USP
Report ID | 122225 |
Drug Identification Number | 02422328 |
Brand name | CEFUROXIME FOR INJECTION, USP |
Common or Proper name | CEFUROXIME FOR INJECTION, USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | CEFUROXIME |
Strength(s) | 7.5G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 VIALS |
ATC code | J01DC |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-07-31 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-08-13 |
Company comments | BUSINESS REASONS. |
Health Canada comments | |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-08-13 | French | Compare |
v1 | 2020-08-13 | English | Compare |